ID   ROR2_HUMAN              Reviewed;         943 AA.
AC   Q01974; Q59GF5; Q5SPI5; Q9HAY7; Q9HB61;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 2.
DT   02-NOV-2010, entry version 123.
DE   RecName: Full=Tyrosine-protein kinase transmembrane receptor ROR2;
DE            EC=2.7.10.1;
DE   AltName: Full=Neurotrophic tyrosine kinase, receptor-related 2;
DE   Flags: Precursor;
GN   Name=ROR2; Synonyms=NTRKR2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ALA-245.
RX   MEDLINE=93100347; PubMed=1334494;
RA   Masiakowski P., Carroll R.D.;
RT   "A novel family of cell surface receptors with tyrosine kinase-like
RT   domain.";
RL   J. Biol. Chem. 267:26181-26190(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 33-943, AND VARIANTS ALA-245
RP   AND ILE-819.
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 34-943, AND VARIANTS ALA-245 AND
RP   ILE-819.
RX   MEDLINE=20164326; PubMed=10700182; DOI=10.1038/73495;
RA   Oldridge M., Fortuna A.M., Maringa M., Propping P., Mansour S.,
RA   Pollitt C., DeChiara T.M., Kimble R.B., Valenzuela D.M.,
RA   Yancopoulos G.D., Wilkie A.O.M.;
RT   "Dominant mutations in ROR2, encoding an orphan receptor tyrosine
RT   kinase, cause brachydactyly type B.";
RL   Nat. Genet. 24:275-278(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 34-574, AND VARIANT ALA-245.
RX   MEDLINE=20442029; PubMed=10986040; DOI=10.1086/303084;
RA   Schwabe G.C., Tinschert S., Buschow C., Meinecke P., Wolff G.,
RA   Gillessen-Kaesbach G., Oldridge M., Wilkie A.O.M., Koemec R.,
RA   Mundlos S.;
RT   "Distinct mutations in the receptor tyrosine kinase gene ROR2 cause
RT   brachydactyly type B.";
RL   Am. J. Hum. Genet. 67:822-831(2000).
RN   [6]
RP   PROTEIN SEQUENCE OF 465-474, SULFATION AT SER-469 AND SER-471, AND
RP   MASS SPECTROMETRY.
RX   PubMed=14752058; DOI=10.1074/mcp.M300140-MCP200;
RA   Medzihradszky K.F., Darula Z., Perlson E., Fainzilber M.,
RA   Chalkley R.J., Ball H., Greenbaum D., Bogyo M., Tyson D.R.,
RA   Bradshaw R.A., Burlingame A.L.;
RT   "O-sulfonation of serine and threonine: mass spectrometric detection
RT   and characterization of a new posttranslational modification in
RT   diverse proteins throughout the eukaryotes.";
RL   Mol. Cell. Proteomics 3:429-440(2004).
RN   [7]
RP   INTERACTION WITH YWHAB, FUNCTION IN YWHAB PHOSPHORYLATION,
RP   DIMERIZATION, AND MASS SPECTROMETRY.
RX   PubMed=17717073; DOI=10.1210/me.2007-0323;
RA   Liu Y., Ross J.F., Bodine P.V.N., Billiard J.;
RT   "Homodimerization of Ror2 tyrosine kinase receptor induces 14-3-
RT   3(beta) phosphorylation and promotes osteoblast differentiation and
RT   bone formation.";
RL   Mol. Endocrinol. 21:3050-3061(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-449, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [9]
RP   VARIANTS RRS CYS-184; TRP-189; TRP-366 AND LYS-620.
RX   MEDLINE=20392394; PubMed=10932186; DOI=10.1038/78107;
RA   Afzal A.R., Rajab A., Fenske C.D., Oldridge M., Elanko N.,
RA   Ternes-Pereira E., Tueysuez B., Murday V.A., Patton M.A.,
RA   Wilkie A.O.M., Jeffery S.;
RT   "Recessive Robinow syndrome, allelic to dominant brachydactyly type B,
RT   is caused by mutation of ROR2.";
RL   Nat. Genet. 25:419-422(2000).
RN   [10]
RP   VARIANT RRS TYR-182.
RX   MEDLINE=20392395; PubMed=10932187; DOI=10.1038/78113;
RA   van Bokhoven H., Celli J., Kayserili H., van Beusekom E., Balci S.,
RA   Brussel W., Skovby F., Kerr B., Percin E.F., Akarsu N., Brunner H.G.;
RT   "Mutation of the gene encoding the ROR2 tyrosine kinase causes
RT   autosomal recessive Robinow syndrome.";
RL   Nat. Genet. 25:423-426(2000).
RN   [11]
RP   ERRATUM.
RX   PubMed=11062486; DOI=10.1038/81722;
RA   van Bokhoven H., Celli J., Kayserili H., van Beusekom E., Balci S.,
RA   Brussel W., Skovby F., Kerr B., Percin E.F., Akarsu N., Brunner H.G.;
RL   Nat. Genet. 26:383-383(2000).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLN-244; ALA-245; ASP-349; ALA-490;
RP   GLN-530; MET-542; SER-548; LEU-557; ASN-644; ASN-672; ARG-695;
RP   CYS-738; LEU-762; ILE-819 AND GLU-935.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Tyrosine-protein kinase receptor which may be involved
CC       in the early formation of the chondrocytes. It seems to be
CC       required for cartilage and growth plate development.
CC       Phosphorylates YWHAB, leading to induction of osteogenesis and
CC       bone formation.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBUNIT: Homodimer; promotes osteogenesis. Binds YWHAB.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- DEVELOPMENTAL STAGE: Expressed at high levels during early
CC       embryonic development. The expression levels drop strongly around
CC       day 16 and there are only very low levels in adult tissues.
CC   -!- PTM: Phosphorylated upon DNA damage, probably by ATM or ATR.
CC   -!- DISEASE: Defects in ROR2 are a cause of brachydactyly type B1
CC       (BDB1) [MIM:113000]. BDB1 is an autosomal dominant skeletal
CC       disorder characterized by hypoplasia/aplasia of distal phalanges
CC       and nails. In BDB1 the middle phalanges are short but in addition
CC       the terminal phalanges are rudimentary or absent. Both fingers and
CC       toes are affected. The thumbs and big toes are usually deformed.
CC   -!- DISEASE: Defects in ROR2 are a cause of recessive Robinow syndrome
CC       (RRS) [MIM:268310]. RRS is an autosomal disorder characterized by
CC       skeletal dysplasia with generalized limb bone shortening,
CC       segmental defects of the spine, brachydactyly and a dysmorphic
CC       facial appearance.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. ROR subfamily.
CC   -!- SIMILARITY: Contains 1 FZ (frizzled) domain.
CC   -!- SIMILARITY: Contains 1 Ig-like C2-type (immunoglobulin-like)
CC       domain.
CC   -!- SIMILARITY: Contains 1 kringle domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92391.1; Type=Erroneous initiation;
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/ROR2";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M97639; AAA60276.1; -; mRNA.
DR   EMBL; AL391219; CAH70208.1; -; Genomic_DNA.
DR   EMBL; AL928802; CAH70208.1; JOINED; Genomic_DNA.
DR   EMBL; AL583841; CAH70208.1; JOINED; Genomic_DNA.
DR   EMBL; AL928802; CAI17303.1; -; Genomic_DNA.
DR   EMBL; AL391219; CAI17303.1; JOINED; Genomic_DNA.
DR   EMBL; AL583841; CAI17303.1; JOINED; Genomic_DNA.
DR   EMBL; AL583841; CAI15694.1; -; Genomic_DNA.
DR   EMBL; AL391219; CAI15694.1; JOINED; Genomic_DNA.
DR   EMBL; AL928802; CAI15694.1; JOINED; Genomic_DNA.
DR   EMBL; AB209154; BAD92391.1; ALT_INIT; mRNA.
DR   EMBL; AF294796; AAG01184.2; -; Genomic_DNA.
DR   EMBL; AF254747; AAG01184.2; JOINED; Genomic_DNA.
DR   EMBL; AF254748; AAG01184.2; JOINED; Genomic_DNA.
DR   EMBL; AF254749; AAG01184.2; JOINED; Genomic_DNA.
DR   EMBL; AF254750; AAG01184.2; JOINED; Genomic_DNA.
DR   EMBL; AF254751; AAG01184.2; JOINED; Genomic_DNA.
DR   EMBL; AF254752; AAG01184.2; JOINED; Genomic_DNA.
DR   EMBL; AF254753; AAG01184.2; JOINED; Genomic_DNA.
DR   EMBL; AF279762; AAG33132.1; -; Genomic_DNA.
DR   EMBL; AF279755; AAG33132.1; JOINED; Genomic_DNA.
DR   EMBL; AF279756; AAG33132.1; JOINED; Genomic_DNA.
DR   EMBL; AF279757; AAG33132.1; JOINED; Genomic_DNA.
DR   EMBL; AF279758; AAG33132.1; JOINED; Genomic_DNA.
DR   EMBL; AF279759; AAG33132.1; JOINED; Genomic_DNA.
DR   EMBL; AF279760; AAG33132.1; JOINED; Genomic_DNA.
DR   EMBL; AF279761; AAG33132.1; JOINED; Genomic_DNA.
DR   IPI; IPI00304999; -.
DR   PIR; B45082; B45082.
DR   RefSeq; NP_004551.2; -.
DR   UniGene; Hs.644776; -.
DR   UniGene; Hs.98255; -.
DR   ProteinModelPortal; Q01974; -.
DR   SMR; Q01974; 64-157, 314-397, 466-748.
DR   STRING; Q01974; -.
DR   PhosphoSite; Q01974; -.
DR   PRIDE; Q01974; -.
DR   Ensembl; ENST00000375708; ENSP00000364860; ENSG00000169071.
DR   GeneID; 4920; -.
DR   KEGG; hsa:4920; -.
DR   UCSC; uc004arj.1; human.
DR   CTD; 4920; -.
DR   GeneCards; GC09M094325; -.
DR   H-InvDB; HIX0034840; -.
DR   HGNC; HGNC:10257; ROR2.
DR   HPA; HPA021868; -.
DR   MIM; 113000; phenotype.
DR   MIM; 268310; phenotype.
DR   MIM; 602337; gene.
DR   Orphanet; 93383; Brachydactyly type B.
DR   Orphanet; 97360; Robinow syndrome.
DR   PharmGKB; PA34629; -.
DR   HOGENOM; HBG281067; -.
DR   HOVERGEN; HBG017736; -.
DR   InParanoid; Q01974; -.
DR   OMA; GSVPETE; -.
DR   PhylomeDB; Q01974; -.
DR   BRENDA; 2.7.10.1; 247.
DR   NextBio; 18945; -.
DR   ArrayExpress; Q01974; -.
DR   Bgee; Q01974; -.
DR   CleanEx; HS_ROR2; -.
DR   Genevestigator; Q01974; -.
DR   GermOnline; ENSG00000169071; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kin...; TAS:ProtInc.
DR   GO; GO:0017147; F:Wnt-protein binding; IPI:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kin...; IEA:InterPro.
DR   InterPro; IPR020067; Frizzled_dom.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000001; Kringle.
DR   InterPro; IPR013806; Kringle-like.
DR   InterPro; IPR018056; Kringle_CS.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR016247; Tyr_kinase_rcpt_ROR_subgr.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   InterPro; IPR020763; Tyr_prot_kinase_rcpt_ROR.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:2.40.20.10; Kringle; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   PANTHER; PTHR23256:SF275; Tyr_prot_kinase_rcpt_ROR; 1.
DR   Pfam; PF01392; Fz; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF00051; Kringle; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PIRSF; PIRSF000624; TyrPK_TMrec_ROR; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00408; IGc2; 1.
DR   SMART; SM00130; KR; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF57440; Kringle-like; 1.
DR   PROSITE; PS50038; FZ; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00021; KRINGLE_1; 1.
DR   PROSITE; PS50070; KRINGLE_2; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Developmental protein;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Glycoprotein; Immunoglobulin domain; Kinase; Kringle; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Receptor; Signal;
KW   Sulfation; Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase.
FT   SIGNAL        1     33       Potential.
FT   CHAIN        34    943       Tyrosine-protein kinase transmembrane
FT                                receptor ROR2.
FT                                /FTId=PRO_0000024460.
FT   TOPO_DOM     34    403       Extracellular (Potential).
FT   TRANSMEM    404    424       Helical; (Potential).
FT   TOPO_DOM    425    943       Cytoplasmic (Potential).
FT   DOMAIN       55    145       Ig-like C2-type.
FT   DOMAIN      169    303       FZ.
FT   DOMAIN      316    394       Kringle.
FT   DOMAIN      473    746       Protein kinase.
FT   NP_BIND     479    487       ATP (By similarity).
FT   COMPBIAS    753    782       Ser/Thr-rich.
FT   COMPBIAS    784    857       Pro-rich.
FT   COMPBIAS    859    882       Ser/Thr-rich.
FT   ACT_SITE    615    615       Proton acceptor (By similarity).
FT   BINDING     507    507       ATP (By similarity).
FT   MOD_RES     449    449       Phosphoserine.
FT   MOD_RES     469    469       Sulfoserine; partial.
FT   MOD_RES     471    471       Sulfoserine; partial.
FT   MOD_RES     646    646       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   CARBOHYD     70     70       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    188    188       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    318    318       N-linked (GlcNAc...) (Potential).
FT   DISULFID     83    135       By similarity.
FT   DISULFID    174    239       By similarity.
FT   DISULFID    182    232       By similarity.
FT   DISULFID    223    264       By similarity.
FT   DISULFID    252    300       By similarity.
FT   DISULFID    256    286       By similarity.
FT   DISULFID    316    394       By similarity.
FT   DISULFID    337    377       By similarity.
FT   DISULFID    365    389       By similarity.
FT   VARIANT     182    182       C -> Y (in RRS).
FT                                /FTId=VAR_010911.
FT   VARIANT     184    184       R -> C (in RRS).
FT                                /FTId=VAR_010768.
FT   VARIANT     189    189       R -> W (in RRS).
FT                                /FTId=VAR_010769.
FT   VARIANT     244    244       R -> Q (in dbSNP:rs55737262).
FT                                /FTId=VAR_041787.
FT   VARIANT     245    245       T -> A (in dbSNP:rs10820900).
FT                                /FTId=VAR_010912.
FT   VARIANT     349    349       H -> D (in dbSNP:rs55983376).
FT                                /FTId=VAR_041788.
FT   VARIANT     366    366       R -> W (in RRS).
FT                                /FTId=VAR_010770.
FT   VARIANT     490    490       G -> A (in dbSNP:rs56197744).
FT                                /FTId=VAR_041789.
FT   VARIANT     530    530       R -> Q (in dbSNP:rs35852786).
FT                                /FTId=VAR_041790.
FT   VARIANT     542    542       V -> M (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041791.
FT   VARIANT     548    548       P -> S (in dbSNP:rs35764413).
FT                                /FTId=VAR_041792.
FT   VARIANT     557    557       S -> L (in dbSNP:rs56099091).
FT                                /FTId=VAR_041793.
FT   VARIANT     620    620       N -> K (in RRS).
FT                                /FTId=VAR_010771.
FT   VARIANT     644    644       D -> N (in dbSNP:rs55798732).
FT                                /FTId=VAR_041794.
FT   VARIANT     672    672       D -> N (in dbSNP:rs55651110).
FT                                /FTId=VAR_041795.
FT   VARIANT     695    695       G -> R (in dbSNP:rs34431454).
FT                                /FTId=VAR_041796.
FT   VARIANT     738    738       R -> C (in dbSNP:rs56231927).
FT                                /FTId=VAR_041797.
FT   VARIANT     762    762       S -> L (in dbSNP:rs34491822).
FT                                /FTId=VAR_041798.
FT   VARIANT     819    819       V -> I (in dbSNP:rs10761129).
FT                                /FTId=VAR_010913.
FT   VARIANT     935    935       D -> E (in dbSNP:rs41277835).
FT                                /FTId=VAR_041799.
SQ   SEQUENCE   943 AA;  104757 MW;  F926FB681A8312FE CRC64;
     MARGSALPRR PLLCIPAVWA AAALLLSVSR TSGEVEVLDP NDPLGPLDGQ DGPIPTLKGY
     FLNFLEPVNN ITIVQGQTAI LHCKVAGNPP PNVRWLKNDA PVVQEPRRII IRKTEYGSRL
     RIQDLDTTDT GYYQCVATNG MKTITATGVL FVRLGPTHSP NHNFQDDYHE DGFCQPYRGI
     ACARFIGNRT IYVDSLQMQG EIENRITAAF TMIGTSTHLS DQCSQFAIPS FCHFVFPLCD
     ARSRTPKPRE LCRDECEVLE SDLCRQEYTI ARSNPLILMR LQLPKCEALP MPESPDAANC
     MRIGIPAERL GRYHQCYNGS GMDYRGTAST TKSGHQCQPW ALQHPHSHHL SSTDFPELGG
     GHAYCRNPGG QMEGPWCFTQ NKNVRMELCD VPSCSPRDSS KMGILYILVP SIAIPLVIAC
     LFFLVCMCRN KQKASASTPQ RRQLMASPSQ DMEMPLINQH KQAKLKEISL SAVRFMEELG
     EDRFGKVYKG HLFGPAPGEQ TQAVAIKTLK DKAEGPLREE FRHEAMLRAR LQHPNVVCLL
     GVVTKDQPLS MIFSYCSHGD LHEFLVMRSP HSDVGSTDDD RTVKSALEPP DFVHLVAQIA
     AGMEYLSSHH VVHKDLATRN VLVYDKLNVK ISDLGLFREV YAADYYKLLG NSLLPIRWMA
     PEAIMYGKFS IDSDIWSYGV VLWEVFSYGL QPYCGYSNQD VVEMIRNRQV LPCPDDCPAW
     VYALMIECWN EFPSRRPRFK DIHSRLRAWG NLSNYNSSAQ TSGASNTTQT SSLSTSPVSN
     VSNARYVGPK QKAPPFPQPQ FIPMKGQIRP MVPPPQLYVP VNGYQPVPAY GAYLPNFYPV
     QIPMQMAPQQ VPPQMVPKPS SHHSGSGSTS TGYVTTAPSN TSMADRAALL SEGADDTQNA
     PEDGAQSTVQ EAEEEEEGSV PETELLGDCD TLQVDEAQVQ LEA
//
